Compared with non/mild NAFLD patients, patients with moderate or severe NAFLD presented a higher BMI and waist circumference and a higher prevalence of insulin resistance and elevated ALT. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.